• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

The Evolving Treatment Paradigm for Plaque Psoriasis

Author(s):

Alexandra K. Golant, MD ,Mona Shahriari, MD, FAAD

Experts in dermatology comment on the impact of both roflumilast and tapinarof on the treatment of plaque psoriasis.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Related Videos
      2 experts in this video
      IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
      2 experts in this video
      Clinical Attributes of IL-17 Inhibitors in Psoriasis
      1 expert in this video
      Talking to Patients on Sunscreen Application and the Effects of Visible Light
      2 experts in this video
      Mechanism of Action Differences Among IL-17 Inhibitors
      2 experts in this video
      The Role of IL-17 in Psoriasis Pathogenesis
      New Research Confirms Effective Therapy for Nail Psoriasis
      New Research Confirms Effective Therapy for Nail Psoriasis
      1 expert in this video
      Personalized Photoprotection Based on Patient Factors
      1 expert in this video
      Impact of Oxidative Stress on Skin Health and the Utility of Antioxidants
      New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
      New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
      1 expert in this video
      Sunscreen Ingredients for UV and Visible Light Protection
      Related Content
      PASI and QoL: A New Approach to Treatment Goals
      March 31st 2025

      PASI and QoL: A New Approach to Treatment Goals

      The Cutaneous Connection: An Inside Look of the Inclusive Atlas
      November 4th 2021

      The Cutaneous Connection: An Inside Look of the Inclusive Atlas

      Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease
      March 25th 2025

      Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease

      The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
      September 23rd 2021

      The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

      Long-Term Safety and Efficacy of Ixekizumab in Japanese Patients with Psoriasis
      March 20th 2025

      Long-Term Safety and Efficacy of Ixekizumab in Japanese Patients with Psoriasis

      Post Hoc Analysis Highlights Zasocitinib’s Efficacy Across Patient Groups
      March 19th 2025

      Post Hoc Analysis Highlights Zasocitinib’s Efficacy Across Patient Groups

      © 2025 MJH Life Sciences

      All rights reserved.